Disease & disorder

ventricular septal defect

MONDO:0002070

The presence of a defect (opening) in the septum that separates the two ventricles of the heart. It can be congenital or acquired.

Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms7

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Ventricular septal defect

A ventricular septal defect (VSD) is a hole in the ventricular septum, the wall dividing the left and right ventricles of the heart. It is a common congenital heart defect, although restrictive muscular VSDs are not true pathological defects; they are typically just a delayed closure of the ventricular septum. They have an extremely high prevalence in newborns. The extent of the opening may vary from pin size to complete absence of the ventricular septum, creating one common ventricle. The ventricular septum consists of an inferior muscular and superior membranous portion and is extensively innervated with conducting cardiomyocytes. The membranous portion, which is close to the atrioventricular node, is most commonly affected in adults and older children in the United States. It is also the type that will most commonly require surgical intervention, comprising over 80% of cases. New research has found that muscular ventricular septal defects are more common than membranous ventricular septal defects, and are the most common congenital cardiac anomaly. Around 3-5% of newborn babies have small muscular VSDs, according to the Copenhagen Baby Heart Study.

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.